researchem retatrutide 30mg Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

If youve been following the rise of GLP-1 medications like semaglutide (Wegovy ) or tirzepatide (Zepbound ), you know theyve reshaped the way many people approach weight loss

You use the pen or syringe to inject the drug into the fatty tissue just under your skin

Phase 3 trials started in 2023 and are ongoing

Of note, the 5-HT 2C receptor was originally classified as 5-HT 1C , however it was reclassified due a shared pharmacological profile with the type 2 receptors [43, 44]

For someone weighing 100 kg, that translates to roughly 5 to 10 kg in three months

All participants also received lifestyle interventions